AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies.
Seely KA, Brents LK, Franks LN, Rajasekaran M, Zimmerman SM, Fantegrossi WE, Prather PL. AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies. Neuropharmacology. 2012 Oct; 63(5):905-15.
-
Analgesics, Non-Narcotic
-
Analgesics, Opioid
-
Animals
-
Binding, Competitive
-
Cannabinoid Receptor Agonists
-
CHO Cells
-
Cricetinae
-
Cricetulus
-
Drug Inverse Agonism
-
Humans
-
Kinetics
-
Mice
-
Mice, Inbred Strains
-
Morpholines
-
Narcotic Antagonists
-
Piperidines
-
Pyrazoles
-
Receptor, Cannabinoid, CB1
-
Receptor, Cannabinoid, CB2
-
Receptors, Opioid, mu
-
Recombinant Proteins